EMPAGLIFLOZIN
Tracking # 20-1055906
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
EMPAGLIFLOZIN IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF TYPE 2 DIABETES MELLITUS. IT IS IN THE SODIUM-GLUCOSE CO-TRANSPORTER (SGLT-2) CLASS OF MEDICATION FOR DIABETES. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR EMPAGLIFLOZIN AS A VALUABLE AGENT IN TREATING TYPE 2 DIABETES MELLITUS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, DOSING, MONITORING PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I